Estefanía Pérez‐López

Analysis of incidence, risk factors and clinical outcome of thromboembolic and bleeding events in 431 allogeneic hematopoietic stem cell transplantation recipients

Jorge Labrador, Lucía López‐Anglada, Estefanía Pérez‐López et al. · Haematologica · 2012 · 86 citations · Full text

Significant Clinical Bleeding, Thrombosis, Venous Thrombosis +18

Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus

Jorge Labrador, Lucía López‐Corral, Oriana López‐Godino et al. · Bone Marrow Transplantation · 2014 · 51 citations

Thrombopoiesis, Thrombosis, Cell Therapy +14

ESHAP as salvage therapy for relapsed or refractory Hodgkin’s lymphoma

Jorge Labrador, Mónica Cabrero, Estefanía Pérez‐López et al. · Annals of Hematology · 2014 · 44 citations

Refractory Hodgkin ’, Lymphoid Neoplasia, Surgical Oncology +6

Minimal residual disease evaluation by flow cytometry is a complementary tool to cytogenetics for treatment decisions in acute myeloid leukaemia

María‐Belén Vídriales, Estefanía Pérez‐López, Carlota Pegenaute et al. · Leukemia Research · 2015 · 34 citations

Hematological Malignancy, Flow Cytometry, Complementary Tool +14

Phase II Study of Yttrium-90-Ibritumomab Tiuxetan as Part of Reduced-Intensity Conditioning (with Melphalan, Fludarabine ± Thiotepa) for Allogeneic Transplantation in Relapsed or Refractory Aggressive B Cell Lymphoma: A GELTAMO Trial

Mónica Cabrero, Alejandro Martı́n, Javier Briones et al. · Biology of Blood and Marrow Transplantation · 2016 · 15 citations · Full text